Despite the prevalence of cancer misinformation, exposure to it is not associated with greater fear of cancer recurrence or ...

A risk score based on four factors — male sex, tumor size, World Health Organization (WHO) grade, and lymphovascular invasion — predicts recurrence in patients with node-negative pancreatic ...

A new tool can help physicians determine which patients with localized pancreatic neuroendocrine tumors (PanNETs) have an ...

The score could help better manage the follow-up care for patients who’ve had pancreatic tumors surgically removed, and whose cancers have not spread to their lymph nodes, researchers wrote Dec. 17 in ...

The new risk score could help better manage the follow-up care for patients who've had pancreatic tumors surgically removed, and whose cancers have not spread to their lymph nodes, researchers wrote ...

The 13-point risk score can help doctors more closely monitor patients at higher risk About 10% of patients suffer a cancer recurrence, most often in their liver FRIDAY, Dec. 19, 2025 (HealthDay News) ...

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring ...

Although three-fourths (76%) of breast cancer patients are exposed to cancer misinformation, perpetuating fear in 38%, it did ...